Abstract
Three members of a family who died with renal amyloidosis were found to share a single nucleotide substitution in the fibrinogen α–chain gene. The predicted arginine to leucine mutation (Arg554Leu) was proven by amino acid sequence analysis of amyloid fibril protein isolated from postmortem kidney of an affected individual. Direct genomic DNA sequencing and restriction fragment length polymorphism analysis demonstrated that all three affected individuals had the guanine to thymine 4993 transversion. This is the first demonstration of hereditary amyloidosis associated with a variant fibrinogen α–chain. Variants of circulating fibrinogen may be the cause of a number of systemic amyloidoses with primarily renal involvement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrade, C. A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75, 408–426 (1952).
Benson, M.D. Inherited amyloidosis. J. med. Genet. 28, 73–78 (1991).
Nichols, W.C., Gregg, R.E., Brewer, Jr., B. & Benson, M.D. A mutation in apolipoprotein A-1 in the Iowa Type of familial amyloidotic polyneuropathy. Genomics 8, 318–323 (1990).
Maury, C.P.J., Kere, J., Tolvanen, R. & de la Chapelle, A. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett. 276, 75–77 (1990).
Levy, E. et al. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J. exp. Med. 172, 1865–1867 (1990).
de la Chapelle, A. et al. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nature Genet. 2, 157–160 (1992).
Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704–706 (1991).
Murrell, J., Farlow, M., Ghetti, B. & Benson, M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97–99 (1991).
Chartier-Harlin, M.C. et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353, 844–846 (1991).
Levy, E. et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124–1126 (1990).
Ghiso, J., Pons-Estel, B. & Frangione, B. Hereditary cerebral amyloid angiopathy: The amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochem. Biophys. Res. Commun. 136, 548–554 (1986).
Hsiao, K. et al. Mutant prion proteins in Gerstmann-Straüssler-Scheinker disease with neurofibrillary tangles. Nature Genet. 1, 68–71 (1992).
Doolittle, R.F., Watt, K.W.K., Cottrell, B.A., Strong, D.D. & Riley, M. The amino acid sequence of the α-chain of human fibrinogen. Nature 280, 464–468 (1979).
Chung, D.W., Harris, J.E. & Davie, E.W. Nucleotide sequences of the three genes coding for human fibrinogen. In Advances in Experimental Medicine and Biology (eds Liu, C.Y. & Chien, S.) 281, 39–48 (Plenum Press, New York, 1991).
Matsuda, M., Yoshida, N., Terukina, S., Yamazumi, K. & Mackawa, H. Molecular abnormalities of fibrinogen—the present status of structure elucidation. In Fibrinogen 4: Current Basic and Clinical Aspects (eds Matsuda, M., Iwanaga, S., Takada, A. & Henschen A.) 139–152 (Excerpta Medica, Amsterdam, 1990).
Benson, M.D. & Wallace, M.R., Amyloidosis. In The Metabolic Basis of Inherited Disease (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 2439–2460. (McGraw Hill, New York, 1989).
Ostertag, B. Familiäre Amyloid-Erkrankung. Z. menschl. Vererb.-u. Konstit.lehre. Bd. 30, 105–115 (1950).
Soutar, A.K. et al. Apolipoprotein Al mutation Arg-60 causes autosomal dominant amyloidosis. Proc. natn. Acad. Sci. U.S.A. 89, 7389–7393 (1992).
Benson, M.D. Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin. J. clin. Invest. 67, 1035–1041 (1981).
Laemmli, U.K. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature 227, 680–685 (1970).
Liepnieks, J.J., Dwulet, F.E. & Benson, M.D. Amino acid sequence of a kappa I primary (AL) amyloid protein (AND). Molec. Immunol. 27, 481–485 (1990).
Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874–879 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benson, M., Liepnieks, J., Uemichi, T. et al. Hereditary renal amyloidosis associated with a mutant fibrinogen α–chain. Nat Genet 3, 252–255 (1993). https://doi.org/10.1038/ng0393-252
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0393-252
This article is cited by
-
Diabetes-Associated Mutations in Proinsulin Provide a “Molecular Rheostat” of Nascent Foldability
Current Diabetes Reports (2022)
-
Typing of hereditary renal amyloidosis presenting with isolated glomerular amyloid deposition
BMC Nephrology (2019)
-
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile
Nature Communications (2016)